SG11201501465SA - Method for screening cancer - Google Patents
Method for screening cancerInfo
- Publication number
- SG11201501465SA SG11201501465SA SG11201501465SA SG11201501465SA SG11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA SG 11201501465S A SG11201501465S A SG 11201501465SA
- Authority
- SG
- Singapore
- Prior art keywords
- screening cancer
- cancer
- screening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2012/001211 WO2014032205A1 (en) | 2012-08-31 | 2012-08-31 | Method for screening cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201501465SA true SG11201501465SA (en) | 2015-05-28 |
Family
ID=50182336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201501465SA SG11201501465SA (en) | 2012-08-31 | 2012-08-31 | Method for screening cancer |
Country Status (15)
Country | Link |
---|---|
US (2) | US10221458B2 (en) |
EP (1) | EP2891720B1 (en) |
JP (1) | JP2015526096A (en) |
KR (1) | KR20150067151A (en) |
CN (1) | CN105579590A (en) |
AU (1) | AU2012388616A1 (en) |
BR (1) | BR112015004423A8 (en) |
CA (1) | CA2883671A1 (en) |
HU (1) | HUE049697T2 (en) |
IL (1) | IL237436A0 (en) |
MX (1) | MX2015002637A (en) |
PH (1) | PH12015500430A1 (en) |
RU (1) | RU2700088C2 (en) |
SG (1) | SG11201501465SA (en) |
WO (1) | WO2014032205A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2891720B1 (en) | 2012-08-31 | 2020-04-08 | National Defense Medical Center | Method for screening cancer |
US20170321247A1 (en) * | 2014-08-18 | 2017-11-09 | Wako Pure Chemical Industries, Ltd. | Cancer marker and cancer determination method |
WO2016060278A1 (en) * | 2014-10-17 | 2016-04-21 | 国立大学法人東北大学 | Method for estimating sensitivity to drug therapy for colorectal cancer |
JP6655243B2 (en) * | 2015-09-01 | 2020-02-26 | 国立大学法人 鹿児島大学 | Method for detecting oral precancerous lesions |
WO2017067477A1 (en) * | 2015-10-20 | 2017-04-27 | Hung-Cheng Lai | Methods for making diagnosis and/or prognosis of gynecologic neoplasm |
WO2018008153A1 (en) * | 2016-07-08 | 2018-01-11 | 有限会社ハヌマット | Method for determining possibility of onset of colon cancer |
GB201703406D0 (en) * | 2017-03-02 | 2017-04-19 | Ucl Business Plc | Diagnostic and prognostic methods |
CN109234378A (en) * | 2018-09-27 | 2019-01-18 | 中国航天员科研训练中心 | Predict the method and DNA methylation marker of weightless bone loss osteocalcin OC downside risk |
EP3950954A4 (en) * | 2018-12-05 | 2022-08-24 | Keio University | Method for determining prognosis of endometrial cancer |
US20230357852A1 (en) * | 2020-08-19 | 2023-11-09 | Mayo Foundation For Medical Education And Research | Detecting non-hodgkin lymphoma |
CN114540489B (en) * | 2020-11-27 | 2024-01-30 | 广州达健生物科技有限公司 | Cervical cancer early screening detection kit and application thereof |
CN113337614A (en) * | 2021-08-05 | 2021-09-03 | 北京起源聚禾生物科技有限公司 | Marker, primer probe and kit for early screening and diagnosis of endometrial cancer |
EP4130297A1 (en) * | 2021-08-05 | 2023-02-08 | Beijing OriginPoly Bio-Tec Co., Ltd. | Markers, primers, probes and kit for early screening and diagnosis of endometrial cancer |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10112515B4 (en) * | 2001-03-09 | 2004-02-12 | Epigenomics Ag | Method for the detection of cytosine methylation patterns with high sensitivity |
US7461163B2 (en) | 2002-08-16 | 2008-12-02 | Infrastructure Innovations Llc | Real time mesh measurement system stream latency and jitter measurements |
US20100273151A1 (en) | 2004-05-28 | 2010-10-28 | Fred Hutchinson Cancer Research Center | Genome-wide analysis of palindrome formation and dna methylation |
US7749702B2 (en) * | 2005-04-15 | 2010-07-06 | Epigenomics Ag | Methods and nucleic acids for the analyses of cellular proliferative disorders |
GB0700374D0 (en) * | 2007-01-09 | 2007-02-14 | Oncomethylome Sciences S A | NDRG family methylation markers |
TW200831900A (en) | 2007-01-23 | 2008-08-01 | Hong-Zheng Lai | Cancer screen method |
EP2118319A4 (en) * | 2007-02-12 | 2010-08-04 | Univ Johns Hopkins | Early detection and prognosis of colon cancers |
US7820386B2 (en) | 2007-06-15 | 2010-10-26 | National Defense Medical Center | Cancer screening method |
JP2009005621A (en) * | 2007-06-28 | 2009-01-15 | Fujifilm Corp | Detection method including malignancy of neuroblastoma and control method |
WO2009105549A2 (en) | 2008-02-19 | 2009-08-27 | Oncomethylome Sciences Sa | Detection and prognosis of lung cancer |
US9850540B2 (en) * | 2008-03-14 | 2017-12-26 | Genomictree, Inc. | Method for detecting lung cancer using lung cancer-specific methylation marker gene |
EP2626435B1 (en) | 2008-03-21 | 2016-06-01 | MDxHealth S.A. | Detection and prognosis of cervical cancer |
CN101570779B (en) * | 2008-04-29 | 2016-02-17 | 赖鸿政 | A kind of method of cancer screening |
US9670546B2 (en) * | 2008-07-15 | 2017-06-06 | Epigenomics Ag | Methods and nucleic acids for analyses of cell proliferative disorders |
TWI385252B (en) | 2009-04-16 | 2013-02-11 | Nat Defense Medical Ct | Cancer screening method |
RU2405837C1 (en) * | 2009-07-06 | 2010-12-10 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) | Early dna-diagnostic technique of prostate cancer |
US8048634B2 (en) | 2009-08-18 | 2011-11-01 | National Defense Medical Center | Cancer screening method |
JP2011160711A (en) | 2010-02-09 | 2011-08-25 | Keio Gijuku | Method for using frequency of methylation of specific gene as biomarker for gynecologic cancer |
US20110301050A1 (en) * | 2010-03-22 | 2011-12-08 | Pfeifer Gerd P | Dna hypermethylation brain cancer markers |
TWI408235B (en) * | 2010-06-03 | 2013-09-11 | Univ China Medical | Gene marker and method for detection of oral cancer |
JP5693895B2 (en) * | 2010-08-26 | 2015-04-01 | 公益財団法人ヒューマンサイエンス振興財団 | Cervical cancer test marker and cervical cancer test method |
WO2012031329A1 (en) | 2010-09-10 | 2012-03-15 | Murdoch Childrens Research Institute | Assay for detection and monitoring of cancer |
CN103703173A (en) * | 2011-02-02 | 2014-04-02 | 精密科学公司 | Digital sequence analysis of dna methylation |
GB201102014D0 (en) * | 2011-02-04 | 2011-03-23 | Ucl Business Plc | Method for predicting risk of developing cancer |
US20130041047A1 (en) | 2011-06-01 | 2013-02-14 | Aros Applied Biotechnology As | Urinary Methylation Markers for Bladder Cancer |
US20130022974A1 (en) | 2011-06-17 | 2013-01-24 | The Regents Of The University Of Michigan | Dna methylation profiles in cancer |
EP2751288A4 (en) | 2011-08-30 | 2015-09-30 | Nat Defense Medical Ct | Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers |
EP2891720B1 (en) | 2012-08-31 | 2020-04-08 | National Defense Medical Center | Method for screening cancer |
-
2012
- 2012-08-31 EP EP12883916.4A patent/EP2891720B1/en active Active
- 2012-08-31 CA CA2883671A patent/CA2883671A1/en not_active Abandoned
- 2012-08-31 HU HUE12883916A patent/HUE049697T2/en unknown
- 2012-08-31 JP JP2015528825A patent/JP2015526096A/en active Pending
- 2012-08-31 US US14/424,876 patent/US10221458B2/en active Active - Reinstated
- 2012-08-31 CN CN201280075471.8A patent/CN105579590A/en active Pending
- 2012-08-31 AU AU2012388616A patent/AU2012388616A1/en not_active Abandoned
- 2012-08-31 SG SG11201501465SA patent/SG11201501465SA/en unknown
- 2012-08-31 BR BR112015004423A patent/BR112015004423A8/en not_active IP Right Cessation
- 2012-08-31 MX MX2015002637A patent/MX2015002637A/en unknown
- 2012-08-31 RU RU2015111627A patent/RU2700088C2/en not_active IP Right Cessation
- 2012-08-31 KR KR1020157007707A patent/KR20150067151A/en not_active Application Discontinuation
- 2012-08-31 WO PCT/CN2012/001211 patent/WO2014032205A1/en active Application Filing
-
2015
- 2015-02-26 IL IL237436A patent/IL237436A0/en unknown
- 2015-02-27 PH PH12015500430A patent/PH12015500430A1/en unknown
-
2019
- 2019-01-11 US US16/246,325 patent/US20190136330A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2014032205A1 (en) | 2014-03-06 |
MX2015002637A (en) | 2015-11-23 |
BR112015004423A2 (en) | 2017-08-08 |
CA2883671A1 (en) | 2014-03-06 |
RU2700088C2 (en) | 2019-09-12 |
US10221458B2 (en) | 2019-03-05 |
EP2891720B1 (en) | 2020-04-08 |
BR112015004423A8 (en) | 2019-01-29 |
IL237436A0 (en) | 2015-04-30 |
EP2891720A4 (en) | 2016-11-09 |
HUE049697T2 (en) | 2020-10-28 |
AU2012388616A1 (en) | 2015-04-02 |
JP2015526096A (en) | 2015-09-10 |
US20150361502A1 (en) | 2015-12-17 |
KR20150067151A (en) | 2015-06-17 |
CN105579590A (en) | 2016-05-11 |
PH12015500430A1 (en) | 2015-04-20 |
US20190136330A1 (en) | 2019-05-09 |
EP2891720A1 (en) | 2015-07-08 |
RU2015111627A (en) | 2016-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL239262A0 (en) | Methods for screening | |
ZA201501833B (en) | Method for obtaining 1-kestone | |
IL237436A0 (en) | Method for screening cancer | |
HK1208709A1 (en) | A method of screening for colorectal cancer | |
GB201212937D0 (en) | Method | |
GB201212932D0 (en) | Method | |
PT2876447T (en) | Method for detecting cancer | |
GB201213636D0 (en) | Method | |
GB201212934D0 (en) | Method | |
GB201210858D0 (en) | Method | |
PL2876446T3 (en) | Method for detecting cancer | |
EP2837619A4 (en) | Method for producing beta -alkoxypropionamide | |
GB201120317D0 (en) | Screening method | |
EP2824130A4 (en) | Method for producing polydialkylsilane | |
EP2758778A4 (en) | Screening method | |
EP2880048A4 (en) | Method | |
EP2894477A4 (en) | Method for determining breast cancer | |
GB201202198D0 (en) | Method | |
SG11201501567QA (en) | Method for producing 7-octenal | |
GB201211393D0 (en) | Method | |
GB201213770D0 (en) | Screening methods | |
GB201214029D0 (en) | method | |
GB201210147D0 (en) | Method | |
IL234526A (en) | Method for producing dithiine tetracarboximides | |
GB201213858D0 (en) | Method |